CRANAD-2 is a specific near-infrared (NIR) fluorescent probe for detecting Abeta plaques (unbound to Abeta: Ex=640 nm, Em=805 nm, after binding: Em=715 nm). CRANAD-2 penetrates the blood-brain barrier and has high affinity for Abeta aggregates, with a Kd value of 38 nM. CRANAD-2 is applicable to research related to Alzheimers disease and neurodegenerative diseases[1][2][3][4].
Molecular Weight:
410.26
Purity:
98
CAS Number:
[1193447-34-5]
Formula:
C23H25BF2N2O2
Target:
Amyloid-beta
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted